FDA tells GLP-1 makers to warn of potential vision loss side effect – The Washington Post

FDA tells GLP-1 makers to warn of potential vision loss side effect  The Washington PostUS FDA orders new eye risk warnings for Ozempic, Zepbound  CNNFDA adds rare vision-loss warning to popular GLP-1 drugs  News4JAXUS is requiring weight-loss drug makers to warn about possible loss of eyesight  The IndependentUS regulator orders blindness risk warning on obesity drugs  Financial Times

সূত্র: মূল সংবাদসূত্র